Showing 11,981 - 12,000 results of 41,842 for search '(( 50 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( a point decrease ))', query time: 0.78s Refine Results
  1. 11981
  2. 11982
  3. 11983
  4. 11984
  5. 11985
  6. 11986
  7. 11987
  8. 11988
  9. 11989
  10. 11990
  11. 11991

    Quantitative Western blot analysis of potential Dube3a targets Eps15 and ATPα. by Laura Jensen (405470)

    Published 2013
    “…Also, a decrease in ATPα can be seen on this particular blot in <i>Dube3a<sup>15b</sup></i> mutants as compare to <i>w<sup>1118</sup>. …”
  12. 11992
  13. 11993
  14. 11994

    <i>chb-3</i> encodes a novel protein with a zf-MYND motif. by Manabi Fujiwara (236721)

    Published 2010
    “…Y50C1, Y2F4 (<i>C. elegans</i> genomic YAC clone), and a Y48G1A.3 PCR fragment (6.5 kb) which contained the Y48G1A.3 predicted gene and 1 kb of upstream sequence, rescued the Daf-c phenotype of <i>chb-3(eg52)</i>. …”
  15. 11995

    Purification and Characterization of the Fe<sup>II</sup>- and α-Ketoglutarate-Dependent Xanthine Hydroxylase from <i>Aspergillus nidulans</i><sup>†</sup> by Gabriela M. Montero-Morán (2493271)

    Published 2007
    “…The αKG cosubstrate can be substituted with α-ketoadipate (9-fold decrease in <i>k</i><sub>cat</sub> and 5-fold increase in the <i>K</i><sub>m</sub> compared to those of the normal α-keto acid), while the αKG analogue <i>N</i>-oxalylglycine is a competitive inhibitor (<i>K</i><sub>i</sub> = 0.12 μM). …”
  16. 11996

    Therapeutic efficacy of Clrn1 re-expression in Müller glia depends on expression level. by Hannah J. T. Nonarath (20861735)

    Published 2025
    “…Error bars=SD. Scale Bar = 50 µm. n=8-12 larvae for each genotype per condition.…”
  17. 11997
  18. 11998
  19. 11999

    Table 1_Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-E... by Natsuda Aumpan (9449957)

    Published 2025
    “…Primary endpoint was clinical response defined by ≥50-point decrease in IBS-symptom severity score (IBS-SSS) at 4 weeks. …”
  20. 12000